Over the last 180 days, OnKure Therapeutics, Inc. insiders sold a net $3.3K of stock across 18 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 13 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | $0 | — | — |
| OPERATING INCOME | $-63.0M | $-54.4M | $-36.9M | $-53.8M |
| NET INCOME | $-59.5M | $-52.7M | $-35.3M | $-52.0M |
| EPS (DILUTED) | -4.40 | -15.28 | -124.41 | -2.12 |
| OPERATING CASH FLOW | $-51.8M | $-51.1M | $-34.5M | $-47.4M |
| CASH | $59.0M | $110.8M | $29.9M | $19.9M |
| BUYBACKS | — | — | $4.4M | — |
No password to create and no card required. We store your email address and nothing else.